While Sibley remains engaged in a daily effort to manage drug shortages for scores of formulary products, some product lines have improved, e.g., injectable opioids, sterile IV solutions and some medications for the code carts. Consequently, originally stocked commercial products e.g., epinephrine injection 1mg/10ml syringes will be reintroduced to the code carts and fentanyl injection 2ml and 5ml restocked in the authorized areas.
In addition to the weekly Drug Shortage Report distributed via email to medical and hospital staff, we want to highlight a few products. The supply of some of our plain local anesthetics, e.g., lidocaine 1% and 2% as well as bupivacaine 0.25% are low and declining. Promethazine 25mg/ml injection is unavailable from suppliers and pharmacy stock is low. A unique medication for urinary spasm/pain, B&O suppositories (both strengths) is about to be completely out of stock.
The pharmacy department lists alternative medications available within the hospital for products in short supply in our weekly report. Discussions are ongoing with the Pharmacy and Therapeutics Committee and key stakeholders to establish alternate operational plans, i.e., for shortages of local anesthetics. Your feedback and questions are encouraged as well. If you need a copy of the weekly Drug Shortage Report please contact your department chairperson, department manager or request a copy from the pharmacy. If you have any questions or comments, please contact the pharmacy department at 202-537-4171. Thank you for your attention to this matter.